A generic method to detect electrophilic intermediates using isotopic pattern triggered data-dependent high-resolution accurate mass spectrometry

被引:61
作者
Lim, Heng-Keang [1 ]
Chen, Jie [1 ]
Cook, Kevin [1 ]
Sensenhauser, Carlo [1 ]
Silva, Jose [1 ]
Evans, David C. [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res Inst, OMP, Drug Metab & Pharmacokinet, Global Preclin Dev, Raritan, NJ 08869 USA
关键词
D O I
10.1002/rcm.3504
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A need still exists for a liquid chromatography/tandem mass spectrometry (LC/MS/MS) method that can detect broad classes of glutathione (GSH) conjugates and provide characterization of their structures. We now describe the development of a method that multiplexes high-resolution accurate mass analysis with isotope pattern triggered data-dependent product ion scans, for simultaneous detection and structural elucidation of GSH conjugates within a single analysis using a LTQ/Orbitrap. This method was initially developed to detect GSH conjugates generated from incubating 10 mu M test compound with pooled human liver microsomes fortified with NADPH-regenerating system and a 2:1 ratio of 5 mM glutathione and [13 (C2N)-N-15-Gly]glutathione. The GSH conjugates were detected by isotope search of mass defect filtered and control subtracted full scan accurate MS data using MetWorks software. This was followed by elucidation of reactive intermediate structures using chemical formulae for both protonated molecules and their product ions from accurate masses in a single analysis. The mass accuracies measured for the precursor and product ions by the Orbitrap were < 2 ppm in external mass calibration mode. Successful detection and characterization of GSH conjugates of acetaminophen, tienilic acid, clozapine, ticlopidine and mifepristone validated this method. In each case, the detected GSH conjugates were within the top five hits by isotope search. This method also has a broader detection capability since it is independent of the collision-induced dissociation behavior of the GSH conjugates. Furthermore, this method is amenable to a broad class of reactive intermediate trapping agents as exemplified by the simultaneous detection and structural elucidation of the cyano-N-methylene iminium ion conjugates of verapamil and its O-desmethyl metabolites, which we report for the first time. In addition to the chemically tagged reactive intermediates, this method also provides information on stable metabolites from the full scan accurate MS data. Copyright (c) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:1295 / 1311
页数:17
相关论文
共 34 条
[1]   Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS/MS) [J].
Argoti, D ;
Liang, L ;
Conteh, A ;
Chen, LF ;
Bershas, D ;
Yu, CP ;
Vouros, P ;
Yang, E .
CHEMICAL RESEARCH IN TOXICOLOGY, 2005, 18 (10) :1537-1544
[2]   MASS-SPECTROMETRY IN THE ANALYSIS OF GLUTATHIONE CONJUGATES [J].
BAILLIE, TA ;
DAVIS, MR .
BIOLOGICAL MASS SPECTROMETRY, 1993, 22 (06) :319-325
[3]   A high-throughput liquid chromatography/tandem mass spectrometry method for screening glutathione conjugates using exact mass neutral loss acquisition [J].
Castro-Perez, J ;
Plumb, R ;
Liang, L ;
Yang, E .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2005, 19 (06) :798-804
[4]   Characterization of amino acid on glutathione adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan [J].
Chen, LJ ;
Hecht, SS ;
Peterson, LA .
CHEMICAL RESEARCH IN TOXICOLOGY, 1997, 10 (08) :866-874
[5]   In vitro and in vivo metabolism of a potent and selective integrin αvβ3 antagonist in rats, dogs, and monkeys [J].
Cui, DH ;
Subramanian, R ;
Shou, MG ;
Yu, X ;
Wallace, MA ;
Braun, MP ;
Arison, BH ;
Yergey, JA ;
Prueksaritanont, T .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (08) :848-861
[6]   Negative ion tandem mass spectrometry for the detection of glutathione conjugates [J].
Dieckhaus, CM ;
Fernández-Metzler, CL ;
King, R ;
Krolikowski, PH ;
Baillie, TA .
CHEMICAL RESEARCH IN TOXICOLOGY, 2005, 18 (04) :630-638
[7]  
Dierks EA, 2001, DRUG METAB DISPOS, V29, P23
[8]  
Drexler DM, 1998, RAPID COMMUN MASS SP, V12, P1501, DOI 10.1002/(SICI)1097-0231(19981030)12:20<1501::AID-RCM355>3.3.CO
[9]  
2-N
[10]   Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development [J].
Evans, DC ;
Watt, AP ;
Nicoll-Griffith, DA ;
Baillie, TA .
CHEMICAL RESEARCH IN TOXICOLOGY, 2004, 17 (01) :3-16